Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Anti-abortion provider measure in Trump’s ‘big, beautiful bill’ could spark House GOP rebellion May 12, 2025 Next Post Excellent Gold Intersections Verified at Kiimala Project May 12, 2025 Related Posts Locksley Qualifies for Trading on U.S. OTCQX Market October 13, 2025 Successful Completion-Impurity Removal Neutralization Tests October 13, 2025 Locksley Resources LimitedQualifies for Trading on U.S. OTCQX Market October 13, 2025